
  
    
      
        Introduction_NNP
        Delirium_NNP is_VBZ not_RB a_DT disease_NN in_IN itself_PRP ,_, but_CC a_DT syndrome_NN of_IN
        acute_JJ cerebral_JJ inefficiency_NN affecting_VBG the_DT brain_NN in_IN various_JJ
        ways_NNS ._. It_PRP creates_VBZ a_DT deleterious_JJ effect_NN on_IN cognitive_JJ
        functions_NNS such_JJ as_IN consciousness_NN ,_, orientation_NN ,_, perception_NN ,_,
        attention_NN ,_, short-term_JJ memory_NN ,_, judgment_NN and_CC abstract_JJ
        thinking_NN [_NN 1_CD ,_, 2_CD ]_NN ._. Delirium_NNP is_VBZ a_DT temporary_JJ condition_NN ,_, which_WDT
        can_MD occur_VB suddenly_RB or_CC slowly_RB over_IN a_DT period_NN of_IN hours_NNS or_CC
        days_NNS ._. A_DT single_JJ episode_NN lasts_VBZ up_IN to_TO 1_CD week_NN ._. The_DT symptoms_NNS may_MD
        be_VB so_RB slight_JJ they_PRP go_VBP unnoticed_JJ or_CC so_RB serious_JJ they_PRP could_MD be_VB
        life_NN threatening_VBG ._. The_DT clinical_JJ signs_NNS of_IN delirium_NN are_VBP
        changeable_JJ all_DT day_NN ,_, and_CC are_VBP usually_RB more_RBR serious_JJ during_IN
        early_JJ morning_NN or_CC night_NN ._. Temporary_NNP changes_NNS in_IN clinical_JJ signs_NNS
        are_VBP important_JJ characteristics_NNS of_IN delirium_NN ._. While_IN the_DT
        patient_NN may_MD appear_VB well_RB and_CC communicative_JJ during_IN an_DT
        observation_NN ,_, changes_NNS in_IN orientation_NN could_MD occur_VB a_DT few_JJ
        minutes_NNS later_RB [_NN 1_CD ,_, 3_CD ]_NN ._. Delirium_NNP is_VBZ typically_RB an_DT indicator_NN
        of_IN a_DT physical_JJ pathology_NN and_CC a_DT worsening_VBG prognosis_NN [_NN 1_CD ,_, 4_CD ,_,
        5_CD ,_, 6_CD ]_NN ._. It_PRP is_VBZ commonly_RB unrecognized_JJ or_CC misdiagnosed_JJ by_IN
        physicians_NNS treating_VBG critically_RB ill_JJ patients_NNS ._. The_DT rate_NN of_IN
        misdiagnosis_NNS has_VBZ been_VBN reported_VBN as_IN 32_CD -_: 67_CD %_NN in_IN various_JJ reviews_NNS
        [_NN 6_CD ,_, 7_CD ]_NN ._. Clinical_NNP evaluation_NN is_VBZ the_DT most_RBS important_JJ
        criterion_NN and_CC electroencephalography_NN is_VBZ the_DT most_RBS useful_JJ
        test_NN for_IN diagnosis_NN ._.
        Although_IN delirium_NN can_MD be_VB experienced_VBN in_IN all_DT age_NN groups_NNS ,_,
        it_PRP has_VBZ an_DT increased_VBN frequency_NN at_IN more_JJR advanced_VBD ages_NNS [_NN 2_CD ,_,
        3_CD ]_NN ._. Risk_NN factors_NNS determined_VBN for_IN the_DT syndrome_NN include_VBP :_: age_NN [_NN
        7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD ,_, 12_CD ]_NN ,_, imbalance_NN of_IN electrolyte_NN [_NN 5_CD ,_, 7_CD ,_, 10_CD ]_NN ,_,
        hypotension_NN [_NN 1_CD ,_, 7_CD ]_NN ,_, hyperglycemia_NN [_NN 1_CD ,_, 7_CD ,_, 8_CD ]_NN ,_, azotemia_NN [_NN
        7_CD ,_, 12_CD ]_NN ,_, fever_NN /_NN hypothermia_NN and_CC infections_NNS [_NN 5_CD ,_, 7_CD ,_, 10_CD ,_, 11_CD ,_,
        12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ]_NN ,_, use_NN of_IN multiple_JJ drugs_NNS and_CC withdrawal_NN of_IN
        alcohol_NN [_NN 7_CD ,_, 8_CD ,_, 10_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ]_NN ,_, male_JJ sex_NN [_NN 7_CD ,_,
        10_CD ]_NN ,_, severe_JJ diseases_NNS such_JJ as_IN cancer_NN ,_, cerebrovasculary_JJ or_CC
        cardiopulmonary_JJ disease_NN ,_, malnutrition_NN and_CC burn_VB [_NN 1_CD ,_, 5_CD ,_, 7_CD ,_,
        8_CD ,_, 15_CD ,_, 16_CD ,_, 17_CD ,_, 18_CD ]_NN ,_, patients_NNS who_WP have_VBP been_VBN operated_VBN on_IN and_CC
        kept_VBD in_IN ICUs_NNP [_NN 4_CD ,_, 10_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ,_, 19_CD ]_NN ,_, and_CC
        psychosocial_NN environment_NN [_NN 1_CD ,_, 3_CD ,_, 5_CD ,_, 20_CD ]_NN ._. Furthermore_RB ,_,
        subclinical_JJ cerebral_JJ damage_NN ,_, increased_VBN adenylate_NN cyclase_NN in_IN
        the_DT central_JJ nervous_JJ system_NN ,_, and_CC nutritional_JJ status_NN
        identified_VBN by_IN albumin_NN level_NN are_VBP predisposing_VBG factors_NNS for_IN
        postoperative_JJ delirium_NN [_NN 1_CD ]_NN ._. Interleukin-_NNP 2_CD ,_, monoclonal_NN
        antibodies_NNS and_CC ifosfamide_NN have_VBP also_RB been_VBN suspected_VBN recently_RB
        as_IN factors_NNS [_NN 15_CD ]_NN ._. The_DT aim_NN of_IN the_DT present_JJ study_NN was_VBD to_TO
        confirm_VB and_CC /_NN or_CC determine_VB predisposing_VBG factors_NNS for_IN
        delirium_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        Between_IN January_NNP 1996_CD and_CC 1997_CD ,_, we_PRP screened_VBD prospectively_RB
        for_IN delirium_NN 818_CD consecutive_JJ general_JJ surgery_NN patients_NNS at_IN
        the_DT Dicle-_NNP University_NNP Hospital_NNP ._. All_DT patients_NNS ,_, whether_IN
        hospitalized_VBN for_IN elective_JJ or_CC emergency_NN services_NNS ,_, or_CC whether_IN
        treated_VBN with_IN medication_NN or_CC surgery_NN ,_, were_VBD kept_VBN for_IN a_DT period_NN
        of_IN time_NN in_IN our_PRP$ ICU_NNP ._. Ten_CD nurses_NNS ,_, four_CD physicians_NNS and_CC four_CD
        staff_NN work_NN daily_JJ in_IN the_DT ICU_NNP department_NN ._. The_DT ICU_NNP has_VBZ 24_CD beds_NNS
        with_IN continuous_JJ non-invasive_JJ monitoring_NN and_CC ventilators_NNS ._.
        There_EX are_VBP windows_NNS in_IN the_DT bed_NN areas_NNS of_IN the_DT ICU_NNP ._. Trained_VBN
        clinician-researchers_JJ carried_VBD out_IN daily_RB structured_VBN
        interviewers_NNS with_IN the_DT patients_NNS from_IN admission_NN until_IN
        hospital_NN discharge_NN ._. Suspected_NNP cases_NNS of_IN delirium_NN were_VBD
        identified_VBN during_IN the_DT daily_JJ interview_NN ._. Patients_NNS with_IN
        changes_NNS in_IN their_PRP$ status_NN of_IN consciousness_NN (_( 
        n_NN =_SYM 150_CD )_) were_VBD consulted_VBN by_IN an_DT
        experienced_VBN consultation-liaison_JJ psychiatrist_NN (_( SÖ_NNP )_) ._.
        Delirium_NNP was_VBD defined_VBN as_IN an_DT organic_JJ mental_JJ disorder_NN
        involving_VBG a_DT confusional_NN state_NN with_IN attention_NN deficit_NN ,_,
        disorganized_JJ thinking_NN and_CC a_DT fluctuating_VBG course_NN and_CC acute_JJ
        development_NN ._. The_DT diagnosis_NN of_IN delirium_NN was_VBD based_VBN on_IN the_DT
        criteria_NNS from_IN the_DT Diagnostic_NNP and_CC Statistical_NNP Manual_NNP of_IN
        Mental_NNP Disorders_NNP (_( revised_VBN third_JJ edition_NN )_) and_CC established_VBN
        through_IN a_DT psychiatric_JJ interview_NN (_( Table_NNP 1_LS )_) ._. Patients_NNS who_WP had_VBD
        history_NN of_IN severe_JJ dementia_NN or_CC had_VBD abused_VBN psychoactive_JJ drugs_NNS
        and_CC alcohol_NN were_VBD excluded_VBN from_IN our_PRP$ study_NN ._. Delirium_NNP was_VBD
        diagnosed_VBN in_IN 90_CD patients_NNS ._. Patients_NNS were_VBD divided_VBN into_IN two_CD
        groups_NNS :_: the_DT DG_NNP (_( 
        n_NN =_SYM 90_CD )_) and_CC the_DT NDG_NNP (_( 
        n_NN =_SYM 728_CD )_) ._. Analysis_NNP of_IN whole_JJ blood_NN
        count_NN ,_, arterial_NN blood_NN gases_NNS ,_, biochemistry_NN and_CC urine_NN ,_,
        culture_NN antibiograms_NNS of_IN blood_NN ,_, urine_NN or_CC other_JJ secretions_NNS ,_,
        and_CC radiological_JJ examinations_NNS ,_, such_JJ as_IN chest_NN X-_NNP ray_NN ,_, were_VBD
        performed_VBN on_IN all_DT delirious_JJ and_CC non-delirious_JJ patients_NNS ._. All_DT
        abnormal_JJ findings_NNS during_IN delirium_NN ,_, related_VBN to_TO physical_JJ
        conditions_NNS ,_, laboratory_NN features_NNS ,_, and_CC additional_JJ diseases_NNS ,_,
        were_VBD evaluated_VBN as_IN probable_JJ risk_NN factors_NNS for_IN delirium_NN ._.
        Findings_NNP for_IN risk_NN factors_NNS included_VBD respiratory_JJ disease_NN
        (_( chronic_JJ obstructive_JJ pulmonary_JJ disease_NN ,_, cor_NN pulmonale_NN ,_,
        pneumothorax_NN ,_, hemothorax_NN ,_, etc_FW ._. )_) ,_, symptomatic_JJ infection_NN ,_,
        fever_NN (_( >_NN 38_CD °_NN C_NNP )_) ,_, hypotension_NN (_( symptomatic_JJ ,_, or_CC systolic_JJ
        blood_NN pressure_NN <_NN 80_CD mmHg_NN )_) ,_, anemia_NN (_( <_NN 25_CD %_NN htc_NN )_) ,_,
        hypertension_NN (_( >_NN 90_CD /_NN 160_CD mmHg_NN )_) ,_, hypo_NN /_NN hyperpotassemia_NN (_( <_NN 3_CD
        or_CC >_NN 6_CD mEq_NN /_NN l_NN )_) ,_, hypocalcemia_NN (_( <_NN 8_CD mg_NN /_NN dl_NN )_) ,_,
        hypo_NN /_NN hypernatremia_NN (_( <_NN 130_CD and_CC >_NN 150_CD mmol_NN /_NN l_NN )_) ,_, elevated_VBD
        level_NN of_IN serum_NN urea_NN nitrogen_NN (_( >_NN 100_CD mg_NN /_NN dl_NN )_) ,_, elevated_VBD
        level_NN of_IN hepatic_JJ enzymes_NNS (_( high_JJ alanine_NN aminotransferase_NN ,_,
        high_JJ aspartate_NN aminotranferase_NN )_) ,_, hyperamy-lasemia_JJ (_( >_NN 300_CD
        U_NNP /_NN l_NN )_) ,_, hyperbilirubinemia_NN (_( >_NN 10_CD mg_NN /_NN dl_NN total_JJ bilirubin_NN )_) ,_,
        metabolic_JJ acidosis_NNS ,_, hypoalbuminemia_NN (_( <_NN 3_CD g_SYM /_NN dl_NN )_) ,_,
        hypo_NN /_NN hyperglycemia_NN (_( <_NN 60_CD or_CC >_NN 300_CD mg_NN /_NN dl_NN )_) ,_, cardiac_JJ
        disease_NN (_( symptomatic_JJ coronary_JJ heart_NN disease_NN and_CC
        arrhythmias_NNS ,_, heart_NN failure_NN ,_, etc_FW ._. )_) ,_, emergency_NN admission_NN
        status_NN ,_, age_NN ,_, length_NN of_IN stay_NN in_IN the_DT ICU_NNP (_( LSICU_NNP )_) ,_, length_NN of_IN
        stay_NN in_IN hospital_NN (_( LSH_NNP )_) ,_, and_CC gender_NN ._. Patients_NNS were_VBD grouped_VBN
        according_VBG to_TO their_PRP$ diagnosis_NN ._. The_DT groupings_NNS included_VBD
        hepatobiliopancreatic_JJ diseases_NNS (_( HBP_NNP )_) ,_, fistulas_NNS ,_, traumas_NNS ,_,
        acute_JJ abdominal_NN diseases_NNS ,_, malignancies_NNS ,_, ileus_JJ ,_, and_CC others_NNS ._.
        The_DT patients_NNS who_WP had_VBD delirium_NN were_VBD treated_VBN initially_RB for_IN
        etiological_JJ diseases_NNS ,_, but_CC when_WRB the_DT treatment_NN was_VBD
        insufficient_JJ medication_NN with_IN diazepam_NN or_CC haloperidole_NN was_VBD
        added_VBN ._.
        Biostatistical_NNP evaluation_NN was_VBD carried_VBN out_IN on_IN an_DT
        IBM-compatible_JJ personal_JJ computer_NN using_VBG SPSS_NNP 10_CD ._. 1_LS software_NN ._.
        The_DT Student_NNP 
        t_NN test_NN for_IN continuing_VBG variables_NNS and_CC
        the_DT chi-square_JJ test_NN for_IN categoric_JJ variables_NNS were_VBD used_VBN ._. To_TO
        identify_VB factors_NNS independently_RB related_VBN to_TO the_DT development_NN
        of_IN delirium_NN ,_, we_PRP also_RB performed_VBD forward_RB stepwise_NN
        (_( conditional_JJ )_) logistic_JJ regression_NN ._. 
        P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN
        statistically_RB significant_JJ ._.
      
      
        Results_NNS
        Of_IN 818_CD patients_NNS ,_, 386_CD (_( 47_CD ._. 2_LS %_NN )_) were_VBD male_JJ and_CC 432_CD (_( 52_CD ._. 8_CD %_NN )_)
        were_VBD female_JJ ._. Delirium_NNP developed_VBD in_IN 90_CD of_IN 818_CD patients_NNS
        (_( 11_CD %_NN )_) ._. The_DT cases_NNS of_IN delirium_NN in_IN the_DT DG_NNP were_VBD more_RBR frequent_JJ
        among_IN male_JJ patients_NNS (_( 63_CD ._. 3_LS %_NN )_) than_IN female_JJ patients_NNS (_( 36_CD ._. 7_CD %_NN )_) (_( χ_NN
        2_CD =_SYM 10_CD ._. 5_LS ,_, 
        P_NN =_SYM 0_CD ._. 001_CD )_) ._. The_DT mean_JJ age_NN was_VBD 48_CD ._. 9_CD ±_NN
        18_CD ._. 1_LS and_CC 38_CD ._. 5_LS ±_NN 13_CD ._. 8_CD years_NNS in_IN the_DT DG_NNP and_CC NDG_NNP consecutively_RB
        (_( 
        t_NN =_SYM 6_CD ._. 4_CD ,_, 
        P_NN =_SYM 0_CD ._. 000_CD )_) ._. While_IN 81_CD ._. 1_LS %_NN of_IN delirious_JJ
        patients_NNS were_VBD admitted_VBN in_IN an_DT emergency_NN state_NN ,_, the_DT remaining_VBG
        18_CD ._. 9_CD %_NN was_VBD admitted_VBN in_IN elective_JJ states_NNS ._. Frequency_NNP of_IN
        delirium_NN was_VBD higher_JJR in_IN the_DT patients_NNS admitted_VBN through_IN the_DT
        Emergency_NNP Department_NNP (_( χ_NN 2_CD =_SYM 43_CD ._. 6_CD ,_, 
        P_NN =_SYM 0_CD ._. 000_CD )_) ._. The_DT rate_NN of_IN postoperative_JJ
        delirium_NN was_VBD 10_CD ._. 9_CD %_NN ,_, but_CC there_EX were_VBD no_DT statistical_JJ
        differences_NNS related_VBN to_TO operation_NN between_IN the_DT DG_NNP and_CC NDG_NNP (_( χ_NN
        2_CD =_SYM 0_CD ._. 13_CD ,_, 
        P_NN =_SYM 0_CD ._. 71_CD )_) (_( Table_NNP 2_LS )_) ._. The_DT LSICU_NNP was_VBD
        10_CD ._. 7_CD ±_NN 13_CD ._. 9_CD and_CC 5_CD ._. 6_CD ±_NN 2_CD ._. 9_CD days_NNS in_IN the_DT DG_NNP and_CC NDG_NNP ,_,
        respectively_RB (_( 
        t_NN =_SYM 0_CD ._. 11_CD ,_, 
        P_NN =_SYM 0_CD ._. 000_CD )_) ._. The_DT LSH_NNP was_VBD 15_CD ._. 6_CD ±_NN 16_CD ._. 5_LS
        and_CC 8_CD ._. 1_CD ±_NN 2_CD ._. 7_CD days_NNS in_IN the_DT DG_NNP and_CC NDG_NNP ,_, respectively_RB (_( 
        t_NN =_SYM 11_CD ._. 08_CD ,_, 
        P_NN =_SYM 0_CD ._. 000_CD )_) ._. Delirium_NNP was_VBD diagnosed_VBN in_IN
        12_CD ._. 9_CD %_NN of_IN patients_NNS with_IN HBP_NNP ,_, in_IN 50_CD %_NN of_IN those_DT with_IN fistulas_NNS ,_,
        in_IN 20_CD ._. 8_CD %_NN of_IN those_DT exposed_VBN to_TO trauma_NN ,_, in_IN 8_CD ._. 2_CD %_NN of_IN those_DT with_IN
        acute_JJ abdominal_NN diseases_NNS ,_, in_IN 9_CD ._. 3_CD %_NN of_IN those_DT with_IN
        malignancies_NNS ,_, and_CC in_IN 18_CD ._. 4_LS %_NN of_IN patients_NNS with_IN ileus_JJ (_( Table_NNP
        3_LS )_) ._. Psychomotor_NNP activity_NN increased_VBD in_IN 56_CD ._. 78_CD %_NN of_IN delirious_JJ
        patients_NNS and_CC decreased_VBD in_IN 43_CD ._. 3_LS %_NN ._. Of_IN delirious_JJ patients_NNS ,_,
        31_CD ._. 1_LS %_NN were_VBD treated_VBN with_IN diazepam_NN and_CC 13_CD ._. 3_LS %_NN were_VBD treated_VBN
        with_IN haloperidole_NN ._.
        Table_NNP 4_CD shows_VBZ that_IN the_DT following_VBG factors_NNS were_VBD all_DT
        associated_VBN with_IN an_DT increased_VBN risk_NN of_IN strongly_RB developing_VBG
        delirium_NN :_: respiratory_JJ diseases_NNS (_( OR_NNP =_SYM 30_CD ._. 6_CD ,_, 95_CD %_NN CI_NNP =_SYM
        9_CD ._. 5_CD -_: 98_CD ._. 4_LS )_) ,_, infections_NNS (_( OR_NNP =_SYM 18_CD ._. 0_CD ,_, 95_CD %_NN CI_NNP =_SYM 3_CD ._. 5_CD -_: 90_CD ._. 8_CD )_) ,_, fever_NN
        (_( OR_NNP =_SYM 14_CD ._. 3_LS ,_, 95_CD %_NN CI_NNP =_SYM 4_CD ._. 1_CD -_: 49_CD ._. 3_LS )_) ,_, anemia_NN (_( OR_NNP =_SYM 5_CD ._. 4_CD ,_, 95_CD %_NN CI_NNP =_SYM
        1_CD ._. 6_CD -_: 17_CD ._. 8_CD )_) ,_, hypotension_NN (_( OR_NNP =_SYM 19_CD ._. 8_CD ,_, 95_CD %_NN CI_NNP =_SYM 5_CD ._. 3_CD -_: 74_CD ._. 3_LS )_) ,_,
        hypocalcemia_NN (_( OR_NNP =_SYM 30_CD ._. 9_CD ,_, 95_CD %_NN CI_NNP =_SYM 5_CD ._. 8_CD -_: 163_CD ._. 2_LS )_) ,_, hyponatremia_NN
        (_( OR_NNP =_SYM 8_CD ._. 2_CD ,_, 95_CD %_NN CI_NNP =_SYM 2_CD ._. 5_CD -_: 26_CD ._. 4_LS )_) ,_, azotemia_NN (_( OR_NNP =_SYM 4_CD ._. 6_CD ,_, 95_CD %_NN CI_NNP =_SYM
        1_CD ._. 4_CD -_: 15_CD ._. 6_CD )_) ,_, elevated_VBD liver_NN enzymes_NNS (_( OR_NNP =_SYM 6_CD ._. 3_CD ,_, 95_CD %_NN CI_NNP =_SYM
        1_CD ._. 2_CD -_: 32_CD ._. 2_LS )_) ,_, hyperamylasemia_NN (_( OR_NNP =_SYM 43_CD ._. 4_LS ,_, 95_CD %_NN CI_NNP =_SYM 4_CD ._. 2_CD -_: 442_CD ._. 7_CD )_) ,_,
        hyperbilirubine-mia_JJ (_( OR_NNP =_SYM 8_CD ._. 7_CD ,_, 95_CD %_NN CI_NNP =_SYM 2_CD ._. 0_CD -_: 37_CD ._. 7_CD )_) and_CC
        metabolic_JJ acidosis_NNS (_( OR_NNP =_SYM 4_CD ._. 5_CD ,_, 95_CD %_NN CI_NNP =_SYM 1_CD ._. 1_CD -_: 17_CD ._. 7_CD )_) ._. Delirium_NNP
        was_VBD not_RB correlated_JJ with_IN conditions_NNS such_JJ as_IN hypertension_NN ,_,
        hypo_NN /_NN hyperpotassemia_NN ,_, hypernatremia_NN ,_, hypoalbuminemia_NN ,_,
        hypo_NN /_NN hyperglycemia_NN ,_, cardiac_JJ disease_NN ,_, emergency_NN admission_NN ,_,
        age_NN ,_, LSICU_NNP ,_, LSH_NNP ,_, and_CC gender_NN ._.
      
      
        Discussion_NNP
        Delirium_NNP ,_, a_DT syndrome_NN associated_VBN with_IN long_JJ hospital_NN stays_VBZ
        and_CC high_JJ rates_NNS of_IN morbidity_NN and_CC mortality_NN [_NN 10_CD ]_NN ,_, is_VBZ a_DT sign_NN
        of_IN deterioration_NN in_IN the_DT homeostasis_NNS and_CC physical_JJ status_NN of_IN
        the_DT patient_NN [_NN 17_CD ]_NN ._. Approximately_RB 10_CD -_: 15_CD %_NN of_IN patients_NNS on_IN
        general_JJ surgical_JJ wards_NNS and_CC 15_CD -_: 25_CD %_NN of_IN patients_NNS on_IN general_JJ
        medical_JJ wards_NNS experience_VBP delirium_NN during_IN their_PRP$ hospital_NN
        stay_NN ._. Approximately_RB 30_CD %_NN of_IN patients_NNS in_IN surgical_JJ ICUs_NNP and_CC
        cardiac_JJ ICUs_NNP ,_, and_CC 40_CD -_: 50_CD %_NN of_IN patients_NNS who_WP are_VBP recovering_VBG
        from_IN hip_NN fractures_NNS have_VBP an_DT episode_NN of_IN delirium_NN [_NN 1_CD ,_, 22_CD ]_NN ._.
        The_DT delirium_NN rate_NN is_VBZ 10_CD -_: 40_CD %_NN in_IN cancer_NN patients_NNS [_NN 23_CD ]_NN ,_, but_CC
        increases_NNS to_TO 85_CD %_NN in_IN patients_NNS with_IN advanced_VBD malignancies_NNS [_NN
        15_CD ]_NN ._. Delirium_NNP is_VBZ seen_VBN in_IN 18_CD %_NN of_IN the_DT patients_NNS when_WRB the_DT ICU_NNP
        facility_NN has_VBZ windows_NNS ,_, but_CC rises_VBZ to_TO 40_CD %_NN of_IN the_DT cases_NNS when_WRB
        the_DT ICU_NNP facility_NN has_VBZ no_DT windows_NNS [_NN 11_CD ]_NN ._. It_PRP has_VBZ been_VBN
        determined_VBN that_IN preoperative_JJ risk_NN factors_NNS for_IN delirium_NN were_VBD
        older_JJR age_NN [_NN 24_CD ,_, 25_CD ,_, 26_CD ]_NN ,_, prior_RB cognitive_JJ impairment_NN [_NN 24_CD ,_,
        25_CD ]_NN ,_, pre-existing_JJ cerebrovascular_NN or_CC other_JJ brain_NN diseases_NNS ,_,
        history_NN of_IN prior_JJ delirium_NN [_NN 25_CD ]_NN ,_, preoperative_JJ abnormal_JJ
        sodium_NN [_NN 24_CD ]_NN ,_, vision_NN or_CC hearing_NN impairment_NN [_NN 24_CD ,_, 26_CD ]_NN and_CC
        regular_JJ use_NN of_IN psychotropic_JJ drugs_NNS before_IN admission_NN [_NN 24_CD ]_NN ._.
        In_IN this_DT series_NN ,_, 11_CD %_NN of_IN our_PRP$ patients_NNS had_VBD delirium_NN ;_: 34_CD ._. 4_LS %_NN (_( 
        n_NN =_SYM 31_CD )_) of_IN these_DT were_VBD older_JJR than_IN 60_CD
        years_NNS ._. The_DT youngest_JJS patient_NN was_VBD 15_CD years_NNS old_JJ ,_, and_CC the_DT
        eldest_JJS was_VBD 91_CD years_NNS old_JJ ._. All_DT of_IN our_PRP$ patients_NNS ,_, most_JJS of_IN whom_WP
        were_VBD younger_JJR than_IN 60_CD years_NNS old_JJ ,_, were_VBD kept_VBN in_IN an_DT ICU_NNP with_IN
        windows_NNS ._. This_DT may_MD be_VB responsible_JJ for_IN the_DT low_JJ frequency_NN of_IN
        delirium_NN in_IN this_DT series_NN ._. Although_IN the_DT age_NN of_IN delirious_JJ
        patients_NNS were_VBD higher_JJR than_IN that_DT of_IN the_DT NDG_NNP (_( 
        t_NN =_SYM 6_CD ._. 4_CD ,_, 
        P_NN =_SYM 0_CD ._. 000_CD )_) ,_, age_NN was_VBD not_RB determined_VBN as_IN
        a_DT predicting_VBG factor_NN for_IN delirium_NN (_( 
        P_NN >_NN 0_CD ._. 05_CD ,_, in_IN the_DT logistic_JJ
        regression_NN test_NN )_) in_IN our_PRP$ study_NN ._. The_DT rate_NN of_IN delirium_NN has_VBZ a_DT
        predominance_NN in_IN males_NNS [_NN 10_CD ,_, 27_CD ]_NN ._. We_PRP found_VBD that_IN the_DT number_NN
        of_IN delirious_JJ male_JJ patients_NNS was_VBD significantly_RB higher_JJR than_IN
        female_JJ patients_NNS (_( χ_NN 2_CD =_SYM 10_CD ._. 5_LS ,_, 
        P_NN =_SYM 0_CD ._. 001_CD )_) ,_, although_IN gender_NN was_VBD not_RB a_DT
        predictive_JJ factor_NN for_IN delirium_NN (_( 
        P_NN >_NN 0_CD ._. 05_CD ,_, in_IN the_DT logistic_JJ
        regression_NN )_) ._.
        The_DT prevalence_NN of_IN delirium_NN in_IN the_DT Emergency_NNP Department_NNP
        was_VBD 9_CD ._. 6_CD %_NN [_NN 28_CD ]_NN ._. In_IN this_DT series_NN ,_, the_DT rate_NN of_IN delirium_NN was_VBD
        18_CD ._. 5_LS %_NN in_IN emergency_NN admissions_NNS ,_, similar_JJ to_TO Kishi_NNP 's_POS series_NN
        (_( 16_CD %_NN )_) [_NN 29_CD ]_NN ,_, but_CC emergency_NN admission_NN was_VBD not_RB considered_VBN a_DT
        factor_NN for_IN delirium_NN ._.
        The_DT etiology_NN of_IN delirium_NN is_VBZ complex_JJ and_CC usually_RB consists_VBZ
        of_IN multiple_JJ factors_NNS ._. In_IN 80_CD -_: 95_CD %_NN of_IN delirious_JJ patients_NNS ,_, the_DT
        etiology_NN is_VBZ secondary_JJ to_TO organic_JJ factors_NNS ,_, but_CC it_PRP is_VBZ
        difficult_JJ to_TO interpret_VB further_JJ details_NNS [_NN 5_CD ,_, 6_CD ,_, 7_CD ]_NN ._.
        Imbalances_NNP of_IN electrolytes_NNS ,_, metabolic_JJ changes_NNS ,_, intoxication_NN
        or_CC absence_NN of_IN drugs_NNS ,_, trauma_NN of_IN head_NN and_CC postoperative_JJ state_NN
        are_VBP the_DT most_RBS common_JJ etiological_JJ factors_NNS ._. Other_JJ less_RBR common_JJ
        factors_NNS are_VBP infections_NNS ,_, intracranial_NN lesions_NNS ,_, coma_NN ,_, fever_NN ,_,
        cardiovasculary_JJ diseases_NNS ,_, poisons_NNS ,_, polymedication_NN and_CC
        deficiencies_NNS of_IN vitamins_NNS [_NN 4_CD ,_, 5_CD ,_, 26_CD ,_, 28_CD ,_, 30_CD ]_NN ._.
        Anti-cholinergic_NNP drugs_NNS are_VBP also_RB commonly_RB accused_VBN agents_NNS [_NN
        5_CD ]_NN ._. Surgical_NNP stress_NN and_CC infectious_JJ fever_NN are_VBP common_JJ factors_NNS
        in_IN geriatric_JJ patients_NNS [_NN 14_CD ]_NN ._. Francis_NNP 
        et_CC al_NN [_NN 12_CD ]_NN reported_VBD that_IN abnormal_JJ
        sodium_NN levels_NNS ,_, fever_NN /_NN hypothermia_NN and_CC azotemia_NN were_VBD
        independent_JJ predictors_NNS for_IN delirium_NN in_IN elderly_JJ patients_NNS ._.
        Foreman_NNP [_NN 31_CD ]_NN determined_VBN that_DT hypernatremia_NN ,_, hypokalemia_NN ,_,
        hyperglycemia_NN ,_, azotemia_NN ,_, hypotension_NN and_CC polymedication_NN
        were_VBD predictors_NNS for_IN delirium_NN in_IN a_DT prospective_JJ study_NN ._. Some_DT
        predisposing_VBG factors_NNS determined_VBN in_IN our_PRP$ study_NN were_VBD
        respiratory_JJ disease_NN (_( 14_CD ._. 1_LS %_NN )_) ,_, hypotension_NN (_( 17_CD %_NN )_) ,_, anemia_NN
        (_( 16_CD ._. 4_LS %_NN )_) ,_, hyponatremia_NN (_( 11_CD ._. 7_CD %_NN )_) ,_, azotemia_NN (_( 10_CD ._. 8_CD %_NN )_) ,_, and_CC
        metabolic_JJ acidosis_NNS (_( 7_CD ._. 6_CD %_NN )_) ._. The_DT major_JJ neurotransmitter_NN
        hypothesized_VBN as_IN involved_VBN in_IN delirium_NN is_VBZ acetylcholine_NN ,_, and_CC
        the_DT major_JJ neuro-anatomical_JJ area_NN is_VBZ the_DT reticular_NN formation_NN
        [_NN 2_CD ]_NN ._. Electrolyte_NNP imbalance_NN and_CC azotemia_NN may_MD be_VB responsible_JJ
        for_IN the_DT decrease_NN in_IN acetylcholine_NN activity_NN in_IN the_DT
        brain_NN ._.
        Symptomatic_NNP infection_NN and_CC fever_NN were_VBD other_JJ independent_JJ
        predictors_NNS of_IN delirium_NN ._. Delirium_NNP has_VBZ been_VBN reported_VBN in_IN
        infectious_JJ diseases_NNS such_JJ as_IN diverticulitis_NNS [_NN 32_CD ]_NN ,_, pneumonia_NN
        [_NN 33_CD ]_NN and_CC typhoid_NN fever_NN [_NN 34_CD ]_NN ._. Certainly_RB ,_, fever_NN is_VBZ
        concomitant_NN with_IN many_JJ infections_NNS and_CC experimental_JJ data_NNS have_VBP
        supported_VBN a_DT casual_JJ relation_NN between_IN fever_NN and_CC delirium_NN ._.
        Fever_NN and_CC infection_NN correlated_JJ with_IN delirium_NN in_IN our_PRP$ study_NN
        as_IN independent_JJ predictors_NNS in_IN the_DT multivariate_NN logistic_JJ
        regression_NN ._. Cytokines_NNP and_CC /_NN or_CC bacterial_JJ toxins_NNS and_CC cerebral_JJ
        metabolic_JJ changes_NNS may_MD be_VB causes_NNS of_IN the_DT mental_JJ changes_NNS
        associated_VBN with_IN infection_NN ._.
        To_TO perform_VB specific_JJ treatment_NN ,_, it_PRP is_VBZ important_JJ to_TO
        determine_VB the_DT etiological_JJ factor_NN ._. Arterial_NNP blood_NN gases_NNS and_CC
        current_JJ and_CC past_JJ vital_JJ signs_NNS should_MD be_VB checked_VBN to_TO establish_VB
        whether_IN cerebral_JJ hypoxemia_NN or_CC hypertensive_JJ encephalopathy_NN
        is_VBZ present_JJ ._. The_DT patient_NN with_IN hypoglycemic-induced_JJ delirium_NN
        virtually_RB always_RB has_VBZ a_DT history_NN of_IN insulin-dependent_JJ
        diabetes_NN mellitus_JJ ._. Hypoglycemic_NNP delirium_NN is_VBZ also_RB
        hyperadrenergic_JJ ._. Hypotension_NNP can_MD result_VB from_IN multiple_JJ
        etiologies_NNS ,_, such_JJ as_IN decreased_VBN cardiac_JJ output_NN from_IN a_DT
        myocardial_NN infarction_NN ,_, cardiac_JJ failure_NN or_CC arrhythmias_NNS ,_, and_CC
        anemia_NN ._. All_DT medical_JJ conditions_NNS that_WDT cause_VBP hypotension_NN can_MD
        lead_VB to_TO a_DT decrease_NN in_IN brain_NN oxygenation_NN [_NN 1_CD ]_NN ._. In_IN this_DT
        study_NN ,_, we_PRP predicted_VBD that_IN respiratory_JJ diseases_NNS ,_, anemia_NN ,_, and_CC
        hypotension_NN were_VBD effective_JJ in_IN delirium_NN by_IN decreasing_VBG brain_NN
        oxygenation_NN ._.
        Research_NNP into_IN patients_NNS who_WP developed_VBD hepatic_JJ failure_NN
        suggests_VBZ that_IN the_DT gamma-aminobutyric_JJ acid_NN system_NN is_VBZ
        important_JJ in_IN the_DT development_NN of_IN hepatic_JJ encephalopathy_NN
        (_( i_NNP ._. e_SYM ._. hypoactive_JJ delirium_NN caused_VBN by_IN liver_NN dysfunction_NN )_) ._.
        Specifically_RB ,_, endogenous_JJ benzodiazepine-like_JJ substances_NNS may_MD
        play_VB a_DT role_NN in_IN delirium_NN associated_VBN with_IN hepatic_JJ failure_NN [_NN
        1_CD ]_NN ._. In_IN our_PRP$ study_NN ,_, delirium_NN was_VBD seen_VBN in_IN 12_CD ._. 9_CD %_NN of_IN HBP_NNP ._. The_DT
        abnormalities_NNS ,_, such_JJ as_IN elevated_JJ level_NN of_IN hepatic_JJ enzymes_NNS ,_,
        hyperbilirubinemia_NN ,_, hypocalcemia_NN and_CC hyperamylasemia_NN
        associated_VBN with_IN HBP_NNP ,_, were_VBD strongly_RB predictive_JJ factors_NNS for_IN
        delirium_NN ._. This_DT condition_NN showed_VBD that_IN early_JJ intervention_NN was_VBD
        important_JJ in_IN HBP_NNP cases_NNS ._.
        The_DT existence_NN of_IN hyperactive_JJ ,_, hypoactive_JJ ,_, or_CC mixed_JJ
        clinical_JJ subtypes_NNS of_IN delirium_NN is_VBZ widely_RB accepted_VBN ._. The_DT
        hyperactive_JJ subtype_NN was_VBD more_RBR frequent_JJ (_( 46_CD ._. 5_LS %_NN )_) than_IN the_DT
        unspecified_JJ (_( 27_CD ._. 3_LS %_NN )_) and_CC hypoactive_JJ subtypes_NNS (_( 26_CD ._. 2_LS %_NN )_) [_NN 35_CD ]_NN ._.
        In_IN a_DT series_NN consisting_VBG of_IN cancer_NN patients_NNS ,_, it_PRP was_VBD observed_VBN
        that_IN the_DT hyperactive_JJ type_NN (_( which_WDT has_VBZ a_DT shorter_JJR duration_NN )_) is_VBZ
        the_DT most_RBS commonly_RB seen_VBN subtype_NN of_IN delirium_NN ,_, with_IN a_DT rate_NN of_IN
        71_CD %_NN [_NN 36_CD ]_NN ._. In_IN our_PRP$ study_NN ,_, 56_CD ._. 7_CD %_NN of_IN delirious_JJ patients_NNS had_VBD
        hyperactive_JJ subtype_NN ._.
        There_EX is_VBZ no_DT specific_JJ drug_NN used_VBN for_IN management_NN of_IN
        delirium_NN ._. The_DT first_JJ step_NN of_IN treatment_NN is_VBZ trying_VBG to_TO calm_VB
        down_RP the_DT patient_NN and_CC to_TO identify_VB the_DT underlying_VBG cause_NN [_NN 1_CD ,_,
        3_CD ,_, 13_CD ]_NN ._. The_DT second_JJ step_NN is_VBZ treating_VBG the_DT causative_JJ factors_NNS ,_,
        when_WRB determinable_JJ ._. If_IN causative_JJ factors_NNS are_VBP undeterminable_JJ ,_,
        then_RB efforts_NNS should_MD be_VB directed_VBN to_TO preventing_VBG permanent_JJ
        damage_NN [_NN 1_CD ,_, 3_CD ]_NN ._. Butyrophenones_NNP (_( haloperidole_NN ,_, thiothixene_NN
        and_CC droperidole_NN )_) ,_, and_CC benzodiazepins_NNS (_( diazepam_NN ,_, oksazepam_NN
        and_CC lorazepam_NN )_) are_VBP the_DT recommended_VBN drugs_NNS for_IN sedation_NN and_CC
        preventing_VBG agitation_NN [_NN 16_CD ,_, 37_CD ,_, 38_CD ]_NN ._. In_IN this_DT series_NN ,_, we_PRP
        treated_VBD the_DT etiological_JJ factors_NNS in_IN all_DT patients_NNS and_CC gave_VBD
        diazepam_NN to_TO 31_CD ._. 1_LS %_NN of_IN the_DT patients_NNS and_CC haloperidole_NN to_TO 13_CD ._. 3_LS %_NN
        of_IN the_DT patients_NNS ._.
        Both_DT surgeons_NNS and_CC anesthesiologists_NNS could_MD reduce_VB the_DT
        incidence_NN of_IN delirium_NN in_IN the_DT patients_NNS who_WP are_VBP at_IN high_JJ risk_NN
        by_IN carefully_RB ordering_VBG and_CC monitoring_VBG the_DT dosages_NNS of_IN drugs_NNS ,_,
        and_CC watching_VBG for_IN signs_NNS of_IN cardiac_JJ ischemia_NN during_IN the_DT
        perioperative_JJ period_NN [_NN 8_CD ,_, 10_CD ]_NN ._.
        The_DT practice_NN of_IN polymedication_NN should_MD not_RB be_VB given_VBN up_RP [_NN
        8_CD ,_, 30_CD ]_NN ._. The_DT goal_NN in_IN diagnosis_NN is_VBZ to_TO discover_VB reversible_JJ
        causes_NNS for_IN delirium_NN ._. In_IN this_DT study_NN series_NN ,_, we_PRP determined_VBD
        that_WDT conditions_NNS such_JJ as_IN disease_NN or_CC symptom_NN variables_NNS
        (_( respiratory_JJ diseases_NNS ,_, symptomatic_JJ infections_NNS ,_, fever_NN ,_,
        anemia_NN ,_, hypotension_NN )_) and_CC laboratory_NN variables_NNS
        (_( hypocalcemia_NN ,_, hyponatremia_NN ,_, azotemia_NN ,_, elevated_VBD liver_NN
        enzymes_NNS ,_, hyperamylasemia_NN ,_, hyperbilirubinemia_NN ,_, and_CC metabolic_JJ
        acidosis_NNS )_) were_VBD predicting_VBG factors_NNS for_IN delirium_NN ._. Clinicians_NNP
        must_MD identify_VB specific_JJ etiologies_NNS when_WRB possible_JJ and_CC apply_VB
        appropriate_JJ treatment_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Abbreviations_NNP
        CI_NNP =_SYM confidence_NN interval_NN ;_: DG_NNP =_SYM delirious_JJ group_NN ;_: HBP_NNP =_SYM
        hepatobiliopancreatic_JJ diseases_NNS ;_: ICU_NNP =_SYM intensive_JJ care_NN unit_NN ;_:
        LSH_NNP =_SYM length_NN of_IN stay_NN in_IN hospital_NN ;_: LSICU_NNP =_SYM length_NN of_IN stay_NN in_IN
        the_DT ICU_NNP ;_: NDG_NNP =_SYM non-delirious_JJ group_NN ;_: OR_NNP =_SYM odds_NNS ratio_NN ._.
      
    
  
